Back to Orbis Allan Gray Ltd Orbis Allan Gray Ltd

ALNYALNY
Showing 8 of 11 quarters

Position history for Orbis Allan Gray LtdOrbis Allan Gray Ltd's holdings in ALNYLAM PHARMACEUTICALS INC

Orbis Allan Gray Ltd holds 2M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $598.3M as of 2026-Q2. The position was increased (+48.9% shares). ALNY represents 2.1% of Orbis Allan Gray Ltd's portfolio.

Current Value

$598.3M

Current Shares

2M

Total Value Change

+$249.5M

Total Shares Change

+719,295

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+48.9%
$598.3M2.1%$301.03
74
2026-Q1
Decreased
1.3M
-17.5%
$441.7M1.9%$330.87
0
2025-Q4
Decreased
1.6M
-17.1%
$643.5M2.7%$397.65
0
2025-Q3
Decreased
2M
-8.0%
$889.6M3.8%$456.00
0
2025-Q2
Increased
2.1M
+29.8%
$691.8M3.4%$326.09
73
2025-Q1
Increased
1.6M
+11.0%
$441.5M2.5%$270.02
59
2024-Q4
Increased
1.5M
+16.1%
$346.6M1.9%$235.31
57
2024-Q3
Increased
1.3M
+75.9%
$348.8M1.8%$275.03
74

Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used